Our results reveal that metabolic control of N-Myc induced neuroblastomas differs from that of c-Myc transformed Burkitt's lymphomas, with one of the checkpoints being differential regulation of GLS1 versus GLS2 activation. This evidence concerns the gene GLS and Burkitt lymphoma.